| Mrs Miranda R Hernly, APRN | |
|
25 W Main St, Austin, IN 47102-1303 | |
| (812) 794-8100 | |
| Not Available |
| Full Name | Mrs Miranda R Hernly |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 25 W Main St, Austin, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831815216 | NPI | - | NPPES |
| 300069066 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 71013171A (Indiana) | Primary |
| Entity Name | Well Care Community Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427694314 PECOS PAC ID: 9335576131 Enrollment ID: O20200217000539 |
News Archive
Eating just one serving of green leafy vegetables or three servings of fruit a day reduces the risk of developing Type II diabetes, say researchers at Tulane School of Public Health and Tropical Medicine and the Harvard School of Public Health.
Genzyme, a Sanofi company, announced today that new longer-term data on its relapsing multiple sclerosis treatments, Aubagio (teriflunomide) and Lemtrada (alemtuzumab), will be featured during the 67th annual meeting of the American Academy of Neurology being held in Washington, D.C. April 18-25.
Aerpio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases, today announced that it has dosed the first patient in a Phase 2 trial evaluating AKB-9778, a Tie2 activator, alone and in combination with ranibizumab (Lucentis) for the treatment of diabetic macular edema (DME). AKB-9778 is a first-in-class inhibitor of human protein tyrosine phosphatase beta (HPTPβ) that activates the Tie2 pathway to promote vascular stability, preventing abnormal blood vessel growth and vascular leak.
Between 2007 and 2010, the use of robotically-assisted hysterectomy for benign gynecologic disorders increased substantially, although, when compared with laparoscopic hysterectomy, the robotic procedure appears to offer little short-term benefit and is accompanied by significantly greater costs, according to a study appearing in the February 20 issue of JAMA.
An Indiana University Melvin and Bren Simon Comprehensive Cancer Center researcher has been awarded a five-year, $2.9 million grant from the National Cancer Institute to develop a drug that could make radiation therapy far more effective.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Miranda R Hernly, APRN 203 E Main St, Richmond, IN 47374-4208 Ph: (765) 973-9294 | Mrs Miranda R Hernly, APRN 25 W Main St, Austin, IN 47102-1303 Ph: (812) 794-8100 |
News Archive
Eating just one serving of green leafy vegetables or three servings of fruit a day reduces the risk of developing Type II diabetes, say researchers at Tulane School of Public Health and Tropical Medicine and the Harvard School of Public Health.
Genzyme, a Sanofi company, announced today that new longer-term data on its relapsing multiple sclerosis treatments, Aubagio (teriflunomide) and Lemtrada (alemtuzumab), will be featured during the 67th annual meeting of the American Academy of Neurology being held in Washington, D.C. April 18-25.
Aerpio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases, today announced that it has dosed the first patient in a Phase 2 trial evaluating AKB-9778, a Tie2 activator, alone and in combination with ranibizumab (Lucentis) for the treatment of diabetic macular edema (DME). AKB-9778 is a first-in-class inhibitor of human protein tyrosine phosphatase beta (HPTPβ) that activates the Tie2 pathway to promote vascular stability, preventing abnormal blood vessel growth and vascular leak.
Between 2007 and 2010, the use of robotically-assisted hysterectomy for benign gynecologic disorders increased substantially, although, when compared with laparoscopic hysterectomy, the robotic procedure appears to offer little short-term benefit and is accompanied by significantly greater costs, according to a study appearing in the February 20 issue of JAMA.
An Indiana University Melvin and Bren Simon Comprehensive Cancer Center researcher has been awarded a five-year, $2.9 million grant from the National Cancer Institute to develop a drug that could make radiation therapy far more effective.
› Verified 7 days ago
Mrs. Hannah Mae Henson, RN, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 25 W Main St, Austin, IN 47102 Phone: 812-794-8100 Fax: 812-794-8200 | |
Jessica Kehl, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 25 W Main St, Austin, IN 47102 Phone: 812-794-8100 | |
Mrs. Roberta Darlene Kilburn, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2277 W Frontage Rd, Austin, IN 47102 Phone: 812-280-2080 Fax: 812-206-1243 | |
Mrs. Jennifer Winans, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 25 W Main St, Austin, IN 47102 Phone: 812-794-8100 | |
Katie Jo Jenkins, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 25 W Main St, Austin, IN 47102 Phone: 812-794-8100 |